The global AI Biomedicine Service market was valued at US$ 4133 million in 2025 and is anticipated to reach US$ 7575 million by 2032, at a CAGR of 9.0% from 2026 to 2032.

AI Biomedicine Service Market

AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.

From a multi-dimensional classification and parameterization perspective, the market can be segmented by service focus (AI drug discovery, AI antibody/biologic discovery, AI pathology and biomarker services, AI omics analytics), by delivery model (platform-as-a-service, fee-for-service, co-development partnerships, or risk-sharing milestone models), and by data modality (chemical structures, protein structures, imaging pathology data, genomics, transcriptomics, and multi-omics). Key performance parameters used by customers include hit identification success rates, lead optimization cycles, reduction in wet-lab iterations, model generalizability across targets, and the ability to integrate proprietary datasets securely.

The industry value chain begins upstream with data generation sources such as high-throughput screening labs, biobanks, sequencing providers, and pathology laboratories, alongside cloud and computing infrastructure suppliers. Midstream players are AI Biomedicine Service providers that combine proprietary algorithms, curated datasets, and domain expertise to deliver discovery or analysis services. Downstream customers include pharmaceutical companies, biotech startups, and, increasingly, CROs and CDMOs integrating AI into their service portfolios. Strategic partnerships and long-term collaborations are common, often embedding AI services deeply into clients’ R&D workflows.

From a profitability perspective, AI Biomedicine Services generally exhibit attractive gross margins, typically in the 60–80% range, reflecting their software- and data-driven nature. Margins vary by model: platform subscriptions and recurring service contracts achieve higher margins, while project-based discovery services see lower margins due to scientific labor and validation costs. Market momentum is driven by rising R&D costs, pressure to improve pipeline productivity, and growing acceptance of AI-derived insights by regulators and pharma partners. Key trends include consolidation between AI platforms and CROs, expansion from discovery into preclinical and translational stages, and increasing use of outcome-linked and co-development revenue models.

This report delivers a comprehensive overview of the global AI Biomedicine Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Biomedicine Service. The AI Biomedicine Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI Biomedicine Service market comprehensively. Regional market sizes by Type, by Application, by Data Type & Modality, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI Biomedicine Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AI Biomedicine Service Market Report

Report Metric	Details
Report Name	AI Biomedicine Service Market
Accounted market size in 2025	US$ 4133 million
Forecasted market size in 2032	US$ 7575 million
CAGR	9.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	AI-driven Drug Discovery Services AI-based Preclinical Research Services AI-enabled Clinical Trial Services AI Biomarker & Companion Diagnostic Services Others
Segment by Data Type & Modality	Genomics & Multi-omics AI Services Medical Imaging & Digital Pathology AI Services Chemical & Molecular Structure AI Services Clinical & EHR Data AI Services Others
Segment by Service Delivery Model	Project-based AI Research Services Subscription-based AI Platforms (Service Mode) AI-as-a-Service (API / Cloud-based) Others
Segment by Application	Pharmaceutical & Biotech Companies CRO / CDMO-oriented Companies Academic & Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abcellera Biologics, Evotec, Atomwise, XtalPi, PathAI, Paige AI, HotSpot Therapeutics, Scorpion Therapeutics, Charm Therapeutics, LifeMine Therapeutics, C4XD Discovery, Wave Life Sciences, Westlake Omics, IIpharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Data Type & Modality, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI Biomedicine Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AI Biomedicine Service Market growing?

Ans: The AI Biomedicine Service Market witnessing a CAGR of 9.0% during the forecast period 2026-2032.

What is the AI Biomedicine Service Market size in 2032?

Ans: The AI Biomedicine Service Market size in 2032 will be US$ 7575 million.

Who are the main players in the AI Biomedicine Service Market report?

Ans: The main players in the AI Biomedicine Service Market are Abcellera Biologics, Evotec, Atomwise, XtalPi, PathAI, Paige AI, HotSpot Therapeutics, Scorpion Therapeutics, Charm Therapeutics, LifeMine Therapeutics, C4XD Discovery, Wave Life Sciences, Westlake Omics, IIpharma

What are the Application segmentation covered in the AI Biomedicine Service Market report?

Ans: The Applications covered in the AI Biomedicine Service Market report are Pharmaceutical & Biotech Companies, CRO / CDMO-oriented Companies, Academic & Research Institutes, Others

What are the Type segmentation covered in the AI Biomedicine Service Market report?

Ans: The Types covered in the AI Biomedicine Service Market report are Genomics & Multi-omics AI Services, Medical Imaging & Digital Pathology AI Services, Chemical & Molecular Structure AI Services, Clinical & EHR Data AI Services, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Biomedicine Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 AI-driven Drug Discovery Services

1.2.3 AI-based Preclinical Research Services

1.2.4 AI-enabled Clinical Trial Services

1.2.5 AI Biomarker & Companion Diagnostic Services

1.2.6 Others

1.3 Market by Data Type & Modality

1.3.1 Global AI Biomedicine Service Market Size Growth Rate by Data Type & Modality: 2021 vs 2025 vs 2032

1.3.2 Genomics & Multi-omics AI Services

1.3.3 Medical Imaging & Digital Pathology AI Services

1.3.4 Chemical & Molecular Structure AI Services

1.3.5 Clinical & EHR Data AI Services

1.3.6 Others

1.4 Market by Service Delivery Model

1.4.1 Global AI Biomedicine Service Market Size Growth Rate by Service Delivery Model: 2021 vs 2025 vs 2032

1.4.2 Project-based AI Research Services

1.4.3 Subscription-based AI Platforms (Service Mode)

1.4.4 AI-as-a-Service (API / Cloud-based)

1.4.5 Others

1.5 Market by Application

1.5.1 Global AI Biomedicine Service Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Pharmaceutical & Biotech Companies

1.5.3 CRO / CDMO-oriented Companies

1.5.4 Academic & Research Institutes

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global AI Biomedicine Service Market Perspective (2021–2032)

2.2 Global AI Biomedicine Service Growth Trends by Region

2.2.1 Global AI Biomedicine Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI Biomedicine Service Historic Market Size by Region (2021–2026)

2.2.3 AI Biomedicine Service Forecasted Market Size by Region (2027–2032)

2.3 AI Biomedicine Service Market Dynamics

2.3.1 AI Biomedicine Service Industry Trends

2.3.2 AI Biomedicine Service Market Drivers

2.3.3 AI Biomedicine Service Market Challenges

2.3.4 AI Biomedicine Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Biomedicine Service Players by Revenue

3.1.1 Global Top AI Biomedicine Service Players by Revenue (2021–2026)

3.1.2 Global AI Biomedicine Service Revenue Market Share by Players (2021–2026)

3.2 Global Top AI Biomedicine Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI Biomedicine Service Revenue

3.4 Global AI Biomedicine Service Market Concentration Ratio

3.4.1 Global AI Biomedicine Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Biomedicine Service Revenue in 2025

3.5 Global Key Players of AI Biomedicine Service Head Offices and Areas Served

3.6 Global Key Players of AI Biomedicine Service, Products and Applications

3.7 Global Key Players of AI Biomedicine Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AI Biomedicine Service Breakdown Data by Type

4.1 Global AI Biomedicine Service Historic Market Size by Type (2021–2026)

4.2 Global AI Biomedicine Service Forecasted Market Size by Type (2027–2032)

5 AI Biomedicine Service Breakdown Data by Application

5.1 Global AI Biomedicine Service Historic Market Size by Application (2021–2026)

5.2 Global AI Biomedicine Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AI Biomedicine Service Market Size (2021–2032)

6.2 North America AI Biomedicine Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI Biomedicine Service Market Size by Country (2021–2026)

6.4 North America AI Biomedicine Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Biomedicine Service Market Size (2021–2032)

7.2 Europe AI Biomedicine Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI Biomedicine Service Market Size by Country (2021–2026)

7.4 Europe AI Biomedicine Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI Biomedicine Service Market Size (2021–2032)

8.2 Asia-Pacific AI Biomedicine Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI Biomedicine Service Market Size by Region (2021–2026)

8.4 Asia-Pacific AI Biomedicine Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI Biomedicine Service Market Size (2021–2032)

9.2 Latin America AI Biomedicine Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI Biomedicine Service Market Size by Country (2021–2026)

9.4 Latin America AI Biomedicine Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Biomedicine Service Market Size (2021–2032)

10.2 Middle East & Africa AI Biomedicine Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI Biomedicine Service Market Size by Country (2021–2026)

10.4 Middle East & Africa AI Biomedicine Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abcellera Biologics

11.1.1 Abcellera Biologics Company Details

11.1.2 Abcellera Biologics Business Overview

11.1.3 Abcellera Biologics AI Biomedicine Service Introduction

11.1.4 Abcellera Biologics Revenue in AI Biomedicine Service Business (2021–2026)

11.1.5 Abcellera Biologics Recent Development

11.2 Evotec

11.2.1 Evotec Company Details

11.2.2 Evotec Business Overview

11.2.3 Evotec AI Biomedicine Service Introduction

11.2.4 Evotec Revenue in AI Biomedicine Service Business (2021–2026)

11.2.5 Evotec Recent Development

11.3 Atomwise

11.3.1 Atomwise Company Details

11.3.2 Atomwise Business Overview

11.3.3 Atomwise AI Biomedicine Service Introduction

11.3.4 Atomwise Revenue in AI Biomedicine Service Business (2021–2026)

11.3.5 Atomwise Recent Development

11.4 XtalPi

11.4.1 XtalPi Company Details

11.4.2 XtalPi Business Overview

11.4.3 XtalPi AI Biomedicine Service Introduction

11.4.4 XtalPi Revenue in AI Biomedicine Service Business (2021–2026)

11.4.5 XtalPi Recent Development

11.5 PathAI

11.5.1 PathAI Company Details

11.5.2 PathAI Business Overview

11.5.3 PathAI AI Biomedicine Service Introduction

11.5.4 PathAI Revenue in AI Biomedicine Service Business (2021–2026)

11.5.5 PathAI Recent Development

11.6 Paige AI

11.6.1 Paige AI Company Details

11.6.2 Paige AI Business Overview

11.6.3 Paige AI AI Biomedicine Service Introduction

11.6.4 Paige AI Revenue in AI Biomedicine Service Business (2021–2026)

11.6.5 Paige AI Recent Development

11.7 HotSpot Therapeutics

11.7.1 HotSpot Therapeutics Company Details

11.7.2 HotSpot Therapeutics Business Overview

11.7.3 HotSpot Therapeutics AI Biomedicine Service Introduction

11.7.4 HotSpot Therapeutics Revenue in AI Biomedicine Service Business (2021–2026)

11.7.5 HotSpot Therapeutics Recent Development

11.8 Scorpion Therapeutics

11.8.1 Scorpion Therapeutics Company Details

11.8.2 Scorpion Therapeutics Business Overview

11.8.3 Scorpion Therapeutics AI Biomedicine Service Introduction

11.8.4 Scorpion Therapeutics Revenue in AI Biomedicine Service Business (2021–2026)

11.8.5 Scorpion Therapeutics Recent Development

11.9 Charm Therapeutics

11.9.1 Charm Therapeutics Company Details

11.9.2 Charm Therapeutics Business Overview

11.9.3 Charm Therapeutics AI Biomedicine Service Introduction

11.9.4 Charm Therapeutics Revenue in AI Biomedicine Service Business (2021–2026)

11.9.5 Charm Therapeutics Recent Development

11.10 LifeMine Therapeutics

11.10.1 LifeMine Therapeutics Company Details

11.10.2 LifeMine Therapeutics Business Overview

11.10.3 LifeMine Therapeutics AI Biomedicine Service Introduction

11.10.4 LifeMine Therapeutics Revenue in AI Biomedicine Service Business (2021–2026)

11.10.5 LifeMine Therapeutics Recent Development

11.11 C4XD Discovery

11.11.1 C4XD Discovery Company Details

11.11.2 C4XD Discovery Business Overview

11.11.3 C4XD Discovery AI Biomedicine Service Introduction

11.11.4 C4XD Discovery Revenue in AI Biomedicine Service Business (2021–2026)

11.11.5 C4XD Discovery Recent Development

11.12 Wave Life Sciences

11.12.1 Wave Life Sciences Company Details

11.12.2 Wave Life Sciences Business Overview

11.12.3 Wave Life Sciences AI Biomedicine Service Introduction

11.12.4 Wave Life Sciences Revenue in AI Biomedicine Service Business (2021–2026)

11.12.5 Wave Life Sciences Recent Development

11.13 Westlake Omics

11.13.1 Westlake Omics Company Details

11.13.2 Westlake Omics Business Overview

11.13.3 Westlake Omics AI Biomedicine Service Introduction

11.13.4 Westlake Omics Revenue in AI Biomedicine Service Business (2021–2026)

11.13.5 Westlake Omics Recent Development

11.14 IIpharma

11.14.1 IIpharma Company Details

11.14.2 IIpharma Business Overview

11.14.3 IIpharma AI Biomedicine Service Introduction

11.14.4 IIpharma Revenue in AI Biomedicine Service Business (2021–2026)

11.14.5 IIpharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

HotSpot Therapeutics

Scorpion Therapeutics

LifeMine Therapeutics

IIpharma

Paige.AI

List of Tables

Table 1. Global AI Biomedicine Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of AI-driven Drug Discovery Services

Table 3. Key Players of AI-based Preclinical Research Services

Table 4. Key Players of AI-enabled Clinical Trial Services

Table 5. Key Players of AI Biomarker & Companion Diagnostic Services

Table 6. Key Players of Others

Table 7. Global AI Biomedicine Service Market Size Growth Rate by Data Type & Modality (US$ Million): 2021 vs 2025 vs 2032

Table 8. Key Players of Genomics & Multi-omics AI Services

Table 9. Key Players of Medical Imaging & Digital Pathology AI Services

Table 10. Key Players of Chemical & Molecular Structure AI Services

Table 11. Key Players of Clinical & EHR Data AI Services

Table 12. Key Players of Others

Table 13. Global AI Biomedicine Service Market Size Growth Rate by Service Delivery Model (US$ Million): 2021 vs 2025 vs 2032

Table 14. Key Players of Project-based AI Research Services

Table 15. Key Players of Subscription-based AI Platforms (Service Mode)

Table 16. Key Players of AI-as-a-Service (API / Cloud-based)

Table 17. Key Players of Others

Table 18. Global AI Biomedicine Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global AI Biomedicine Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global AI Biomedicine Service Market Size by Region (US$ Million), 2021–2026

Table 21. Global AI Biomedicine Service Market Share by Region (2021–2026)

Table 22. Global AI Biomedicine Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 23. Global AI Biomedicine Service Market Share by Region (2027–2032)

Table 24. AI Biomedicine Service Market Trends

Table 25. AI Biomedicine Service Market Drivers

Table 26. AI Biomedicine Service Market Challenges

Table 27. AI Biomedicine Service Market Restraints

Table 28. Global AI Biomedicine Service Revenue by Players (US$ Million), 2021–2026

Table 29. Global AI Biomedicine Service Market Share by Players (2021–2026)

Table 30. Global Top AI Biomedicine Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Biomedicine Service Revenue, 2025

Table 31. Ranking of Global Top AI Biomedicine Service Companies by Revenue (US$ Million) in 2025

Table 32. Global 5 Largest Players Market Share by AI Biomedicine Service Revenue (CR5 and HHI), 2021–2026

Table 33. Global Key Players of AI Biomedicine Service, Headquarters and Area Served

Table 34. Global Key Players of AI Biomedicine Service, Products and Applications

Table 35. Global Key Players of AI Biomedicine Service, Date of General Availability (GA)

Table 36. Mergers and Acquisitions, Expansion Plans

Table 37. Global AI Biomedicine Service Market Size by Type (US$ Million), 2021–2026

Table 38. Global AI Biomedicine Service Revenue Market Share by Type (2021–2026)

Table 39. Global AI Biomedicine Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 40. Global AI Biomedicine Service Revenue Market Share by Type (2027–2032)

Table 41. Global AI Biomedicine Service Market Size by Application (US$ Million), 2021–2026

Table 42. Global AI Biomedicine Service Revenue Market Share by Application (2021–2026)

Table 43. Global AI Biomedicine Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 44. Global AI Biomedicine Service Revenue Market Share by Application (2027–2032)

Table 45. North America AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. North America AI Biomedicine Service Market Size by Country (US$ Million), 2021–2026

Table 47. North America AI Biomedicine Service Market Size by Country (US$ Million), 2027–2032

Table 48. Europe AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Europe AI Biomedicine Service Market Size by Country (US$ Million), 2021–2026

Table 50. Europe AI Biomedicine Service Market Size by Country (US$ Million), 2027–2032

Table 51. Asia-Pacific AI Biomedicine Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 52. Asia-Pacific AI Biomedicine Service Market Size by Region (US$ Million), 2021–2026

Table 53. Asia-Pacific AI Biomedicine Service Market Size by Region (US$ Million), 2027–2032

Table 54. Latin America AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Latin America AI Biomedicine Service Market Size by Country (US$ Million), 2021–2026

Table 56. Latin America AI Biomedicine Service Market Size by Country (US$ Million), 2027–2032

Table 57. Middle East & Africa AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 58. Middle East & Africa AI Biomedicine Service Market Size by Country (US$ Million), 2021–2026

Table 59. Middle East & Africa AI Biomedicine Service Market Size by Country (US$ Million), 2027–2032

Table 60. Abcellera Biologics Company Details

Table 61. Abcellera Biologics Business Overview

Table 62. Abcellera Biologics AI Biomedicine Service Product

Table 63. Abcellera Biologics Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 64. Abcellera Biologics Recent Development

Table 65. Evotec Company Details

Table 66. Evotec Business Overview

Table 67. Evotec AI Biomedicine Service Product

Table 68. Evotec Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 69. Evotec Recent Development

Table 70. Atomwise Company Details

Table 71. Atomwise Business Overview

Table 72. Atomwise AI Biomedicine Service Product

Table 73. Atomwise Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 74. Atomwise Recent Development

Table 75. XtalPi Company Details

Table 76. XtalPi Business Overview

Table 77. XtalPi AI Biomedicine Service Product

Table 78. XtalPi Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 79. XtalPi Recent Development

Table 80. PathAI Company Details

Table 81. PathAI Business Overview

Table 82. PathAI AI Biomedicine Service Product

Table 83. PathAI Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 84. PathAI Recent Development

Table 85. Paige AI Company Details

Table 86. Paige AI Business Overview

Table 87. Paige AI AI Biomedicine Service Product

Table 88. Paige AI Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 89. Paige AI Recent Development

Table 90. HotSpot Therapeutics Company Details

Table 91. HotSpot Therapeutics Business Overview

Table 92. HotSpot Therapeutics AI Biomedicine Service Product

Table 93. HotSpot Therapeutics Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 94. HotSpot Therapeutics Recent Development

Table 95. Scorpion Therapeutics Company Details

Table 96. Scorpion Therapeutics Business Overview

Table 97. Scorpion Therapeutics AI Biomedicine Service Product

Table 98. Scorpion Therapeutics Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 99. Scorpion Therapeutics Recent Development

Table 100. Charm Therapeutics Company Details

Table 101. Charm Therapeutics Business Overview

Table 102. Charm Therapeutics AI Biomedicine Service Product

Table 103. Charm Therapeutics Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 104. Charm Therapeutics Recent Development

Table 105. LifeMine Therapeutics Company Details

Table 106. LifeMine Therapeutics Business Overview

Table 107. LifeMine Therapeutics AI Biomedicine Service Product

Table 108. LifeMine Therapeutics Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 109. LifeMine Therapeutics Recent Development

Table 110. C4XD Discovery Company Details

Table 111. C4XD Discovery Business Overview

Table 112. C4XD Discovery AI Biomedicine Service Product

Table 113. C4XD Discovery Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 114. C4XD Discovery Recent Development

Table 115. Wave Life Sciences Company Details

Table 116. Wave Life Sciences Business Overview

Table 117. Wave Life Sciences AI Biomedicine Service Product

Table 118. Wave Life Sciences Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 119. Wave Life Sciences Recent Development

Table 120. Westlake Omics Company Details

Table 121. Westlake Omics Business Overview

Table 122. Westlake Omics AI Biomedicine Service Product

Table 123. Westlake Omics Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 124. Westlake Omics Recent Development

Table 125. IIpharma Company Details

Table 126. IIpharma Business Overview

Table 127. IIpharma AI Biomedicine Service Product

Table 128. IIpharma Revenue in AI Biomedicine Service Business (US$ Million), 2021–2026

Table 129. IIpharma Recent Development

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Authors List of This Report

List of Figures

Figure 1. AI Biomedicine Service Picture

Figure 2. Global AI Biomedicine Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AI Biomedicine Service Market Share by Type: 2025 vs 2032

Figure 4. AI-driven Drug Discovery Services Features

Figure 5. AI-based Preclinical Research Services Features

Figure 6. AI-enabled Clinical Trial Services Features

Figure 7. AI Biomarker & Companion Diagnostic Services Features

Figure 8. Others Features

Figure 9. Global AI Biomedicine Service Market Size Comparison by Data Type & Modality (US$ Million), 2021–2032

Figure 10. Genomics & Multi-omics AI Services Features

Figure 11. Medical Imaging & Digital Pathology AI Services Features

Figure 12. Chemical & Molecular Structure AI Services Features

Figure 13. Clinical & EHR Data AI Services Features

Figure 14. Others Features

Figure 15. Global AI Biomedicine Service Market Size Comparison by Service Delivery Model (US$ Million), 2021–2032

Figure 16. Project-based AI Research Services Features

Figure 17. Subscription-based AI Platforms (Service Mode) Features

Figure 18. AI-as-a-Service (API / Cloud-based) Features

Figure 19. Others Features

Figure 20. Global AI Biomedicine Service Market Size by Application (US$ Million), 2021–2032

Figure 21. Global AI Biomedicine Service Market Share by Application: 2025 vs 2032

Figure 22. Pharmaceutical & Biotech Companies Case Studies

Figure 23. CRO / CDMO-oriented Companies Case Studies

Figure 24. Academic & Research Institutes Case Studies

Figure 25. Others Case Studies

Figure 26. AI Biomedicine Service Report Years Considered

Figure 27. Global AI Biomedicine Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 28. Global AI Biomedicine Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 29. Global AI Biomedicine Service Market Share by Region: 2025 vs 2032

Figure 30. Global AI Biomedicine Service Market Share by Players in 2025

Figure 31. Global AI Biomedicine Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 32. The Top 10 and 5 Players Market Share by AI Biomedicine Service Revenue in 2025

Figure 33. North America AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. North America AI Biomedicine Service Market Share by Country (2021–2032)

Figure 35. United States AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Canada AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Europe AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Europe AI Biomedicine Service Market Share by Country (2021–2032)

Figure 39. Germany AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. France AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. U.K. AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Italy AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Russia AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Ireland AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Asia-Pacific AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Asia-Pacific AI Biomedicine Service Market Share by Region (2021–2032)

Figure 47. China AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Japan AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. South Korea AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Southeast Asia AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. India AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Australia & New Zealand AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Latin America AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Latin America AI Biomedicine Service Market Share by Country (2021–2032)

Figure 55. Mexico AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Brazil AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Middle East & Africa AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Middle East & Africa AI Biomedicine Service Market Share by Country (2021–2032)

Figure 59. Israel AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. Saudi Arabia AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. UAE AI Biomedicine Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 62. Abcellera Biologics Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 63. Evotec Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 64. Atomwise Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 65. XtalPi Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 66. PathAI Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 67. Paige AI Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 68. HotSpot Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 69. Scorpion Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 70. Charm Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 71. LifeMine Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 72. C4XD Discovery Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 73. Wave Life Sciences Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 74. Westlake Omics Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 75. IIpharma Revenue Growth Rate in AI Biomedicine Service Business (2021–2026)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Artificial Intelligence AI in Life Sciences Market Research Report 2024

Medical AI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artificial Intelligence in Drug Discovery Market Size Status and Forecast 2020 2026

Global Drug Discovery AI Tools Market Research Report 2025

Global AI Technology in Healthcare Market Research Report 2024

Global Healthcare AI Market Insights Forecast to 2030

Artificial Intelligence in Healthcare Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artificial Intelligence AI in Medical Market Insights Forecast to 2030

Global AI In Clinical Trials Market Research Report 2024

Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030

Global Artificial Intelligence Systems in Healthcare Market Insights Forecast to 2030

Medical Artificial Intelligence Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Intelligence in Medicine Market

Healthcare Artificial Intelligence Market

Global Ai and Machine Learning Service Market Research Report 2025

Artificial Intelligence AI in Medical Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical AI Data Analysis Market Research Report 2024

Global AI for Drug Discovery and Development Market Research Report 2025

Global Medical Imaging Artificial Intelligence Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions